Thu, October 8, 2009
Wed, October 7, 2009
Tue, October 6, 2009
Mon, October 5, 2009
Sun, October 4, 2009
Fri, October 2, 2009
Thu, October 1, 2009
Wed, September 30, 2009
Tue, September 29, 2009
Mon, September 28, 2009
Fri, September 25, 2009
Thu, September 24, 2009
Wed, September 23, 2009
Tue, September 22, 2009
Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Mon, September 7, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Sun, August 30, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009

Antisoma plc: Antisoma to present at the Bank of America Merrill Lynch Global Healthcare Conference in London


  Copy link into your clipboard //house-home.news-articles.net/content/2009/09/1 .. ynch-global-healthcare-conference-in-london.html
  Print publication without navigation Published in House and Home on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

LONDON and CAMBRIDGE, MA--(Marketwire - September 16, 2009) -


Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an overview of the Company's strategy, programmes and prospects at the Bank of America Merrill Lynch Global Healthcare conference in London, today at 09:50 BST/04:50 EDT.

A webcast of the presentation will be available on Antisoma's website at [ http://www.antisoma.com/asm/media/webcast/ ]

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

 Enquiries: Daniel Elger VP, Marketing and Communications Antisoma plc +44 (0)7909 915 068 

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit [ www.antisoma.com ] for further information about Antisoma.

---END OF MESSAGE---


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Copyright © Hugin AS 2009. All rights reserved.


Publication Contributing Sources